Dr. Stephen Schwartz, MD
What this data tells you about Dr. Schwartz
Dr. Stephen Schwartz is an ophthalmology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Schwartz performed 40,385 Medicare services across 5,688 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schwartz received a total of $1,092 from 16 pharmaceutical and/or device companies across 46 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schwartz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 30,900 | $29 | $90 |
| Retinal photography (fundus photo) | 1,827 | $27 | $289 |
| Eye injection for retinal disease | 1,094 | $97 | $427 |
| Retinal imaging (OCT scan) | 897 | $30 | $167 |
| Eye exam, established patient, focused | 839 | $69 | $194 |
| Aflibercept eye injection (Eylea) | 810 | $689 | $1,388 |
| Comprehensive eye exam, established patient | 764 | $89 | $296 |
| Office visit, established patient (20-29 min) | 699 | $69 | $193 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 690 | $120 | $290 |
| Visual field test, extended | 380 | $44 | $235 |
| Unclassified drugs | 337 | $336 | $988 |
| Injection, ranibizumab, 0.1 mg | 195 | $179 | $500 |
| Comprehensive eye exam, new patient | 192 | $94 | $369 |
| Office visit, established patient (30-39 min) | 187 | $89 | $299 |
| Office visit, established patient (10-19 min) | 99 | $38 | $99 |
| Photography of content of eyes | 89 | $18 | $79 |
| Optic nerve imaging (OCT scan) | 81 | $25 | $161 |
| 2d ultrasound scan of eye tissue and structures | 79 | $35 | $331 |
| Removal of recurring cataract in lens capsule using a laser | 59 | $267 | $1,177 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $72 | $350 |
| Exam of the internal drainage system of eye | 31 | $22 | $77 |
| New patient office visit (45-59 min) | 26 | $113 | $507 |
| Ultrasound scan of cornea to determine thickness | 20 | $8 | $59 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 20 | $142 | $931 |
| Ultrasound scan of eye using water bath method | 15 | $60 | $377 |
| Closure of tear duct opening using plug | 14 | $145 | $670 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Schwartz is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Schwartz experienced with eye injection (vabysmo/faricimab)?
Does Dr. Schwartz receive payments from pharmaceutical companies?
How do Dr. Schwartz's costs compare to other ophthalmologys in Miami?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology